Menu

Bicycle Therapeutics plc BCYC

Full chart Compare
Set alert

Price alert · BCYC

All alert types
3.61 USD +0.13 (+3.74%)

At closeNov 6, 2026, 4:00 PM EST

3.61 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

3.49 Day range 3.69
3.38 52-week range 7.52
YTD
-49.01%
1 year
-44.55%

Revenue & Expenses

Other Income → Expenses: $28.91MExpenses → Selling, General & Admin: $80.02MExpenses → Research & Development: $240.28MExpenses → Income Tax: $152.00KGross Profit → Expenses: $72.59MRevenue → Gross Profit: $72.59MNet Loss → Expenses: $218.96MOther Income$28.91MGross Profit$72.59MNet Loss$218.96MExpenses$320.46MSelling, General & Admin$80.02MResearch & Development$240.28MIncome Tax$152.00KRevenue$72.59M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BCYC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
72.59M35.27M26.98M14.46M11.70M
72.59M35.27M26.98M14.46M11.70M
-247.06M-209.87M-189.95M-116.65M-65.62M
-218.96M-169.03M-180.66M-112.72M-66.82M
-3.16-2.90-5.08-3.80-2.67
BCYC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
628.11M879.52M526.42M339.15M438.68M
717.60M956.87M595.34M410.61M479.79M
107.62M163.81M224.41M139.83M133.54M
14.10M3.99M40.08M41.20M41.95M
609.98M793.06M370.93M270.78M346.25M
BCYC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-249.68M-164.72M-60.63M-86.11M-14.79M
-2.35M-1.24M-2.93M-18.99M-2.03M
-131.00K519.75M250.03M6.69M320.73M
-2.35M-1.24M-2.93M-18.99M-2.03M
-251.35M353.10M187.82M-99.53M302.69M